ES8900170A1 - Procedimiento de modificacion de celulas eucariotas. - Google Patents

Procedimiento de modificacion de celulas eucariotas.

Info

Publication number
ES8900170A1
ES8900170A1 ES548529A ES548529A ES8900170A1 ES 8900170 A1 ES8900170 A1 ES 8900170A1 ES 548529 A ES548529 A ES 548529A ES 548529 A ES548529 A ES 548529A ES 8900170 A1 ES8900170 A1 ES 8900170A1
Authority
ES
Spain
Prior art keywords
cloning
genome
cells transfected
vectors
erythroblastosis virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548529A
Other languages
English (en)
Other versions
ES548529A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Publication of ES548529A0 publication Critical patent/ES548529A0/es
Publication of ES8900170A1 publication Critical patent/ES8900170A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO DE MODIFICACION DE CELULAS EUCARIOTAS EN QUE SE EFECTUA UNA INFECCION O TRANSFECCION DE LAS CELULAS CON UN VECTOR, VIRUS O PLASMIDO, DE CLONADO O DE EXPRESION DE UN GEN EXTRAÑO QUE ESTA TOTAL O PARCIALMENTE POR EL GENOMA DE UN RETROVIRUS Y QUE PRESENTA POR LO MENOS UN GEN EXTRAÑO SITUADO ENTRE LAS 2 SECUENCIAS LTR O UNA TRASFECCION DE LAS CELULAS CON UN PLASMIDO QUE PRESENTA UNA SECUENCIA COMPLEJA DE ADN TRANSCRITO INVERSO DE DICHO VIRUS. EN EL PRIMER MODO DE REALIZACION EL PODER ONCOGENO DEL VIRUS SE UTILIZA COMO MARCADOR DE SELECCION Y SU APTITUD DE INSERCION PARA TRANSFERENCIA EN UNAS CELULAS EN CULTIVO DE UN GEN EXOGENO INSERTADO EN EL RETROVIRUS. EN EL SEGUNDO MODO EL PODER ONCOGENO DEL VIRUS ESTA SUPRIMIDO. LA APLICACION ES LA MEJORA EN EL RENDIMIENTO DE LA TRANSFERENCIA DE MATERIAL GENETICO, POR EJEMPLO OBTENCION DE PROTEINA DE CULTIVO CELULAR.
ES548529A 1984-10-15 1985-10-15 Procedimiento de modificacion de celulas eucariotas. Expired ES8900170A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8415764A FR2571737B1 (fr) 1984-10-15 1984-10-15 Vecteurs de clonage ou d'expression comportant le genome du virus de l'erythroblastose aviaire et cellules transfectees par ces vecteurs

Publications (2)

Publication Number Publication Date
ES548529A0 ES548529A0 (es) 1988-04-16
ES8900170A1 true ES8900170A1 (es) 1988-04-16

Family

ID=9308658

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548529A Expired ES8900170A1 (es) 1984-10-15 1985-10-15 Procedimiento de modificacion de celulas eucariotas.
ES557463A Expired ES8800985A1 (es) 1984-10-15 1987-02-27 Procedimiento de preparar proteinas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557463A Expired ES8800985A1 (es) 1984-10-15 1987-02-27 Procedimiento de preparar proteinas.

Country Status (16)

Country Link
US (1) US4957865A (es)
EP (1) EP0178996B1 (es)
JP (1) JPS62501398A (es)
AT (1) ATE48642T1 (es)
AU (1) AU5010585A (es)
BR (1) BR8506990A (es)
DE (1) DE3574732D1 (es)
DK (1) DK279686D0 (es)
ES (2) ES8900170A1 (es)
FI (1) FI862517A (es)
FR (1) FR2571737B1 (es)
GR (1) GR852500B (es)
NO (1) NO862383D0 (es)
PT (1) PT81306B (es)
WO (1) WO1986002380A1 (es)
ZA (1) ZA857862B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
FR2606030B1 (fr) * 1986-10-31 1989-10-20 Pasteur Institut Retrovirus recombinant defectif, son procede de fabrication et ses applications, notamment pour l'etude de l'interaction des retrovirus sauvages avec des lignees cellulaires infectables par celui-ci
US5256553A (en) * 1987-10-09 1993-10-26 Immunex Corporation Multiple promoter transforming retroviral vectors
FR2622207B1 (fr) * 1987-10-21 1990-03-09 Agronomique Inst Nat Rech Vecteurs d'integration et d'expression d'un gene heterologue, cellules infectees avec ces vecteurs et procede de production d'une proteine ou de modification genetique d'animaux
FR2631974B1 (fr) * 1988-05-31 1992-12-11 Agronomique Inst Nat Rech Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes
US6027722A (en) * 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
DK0506945T3 (da) * 1990-10-25 1999-04-26 Clague Pitman Hodgson Fremgangsmåde til genoverførsel under anvendelse af retrotransposoner
US6300058B1 (en) * 1992-01-29 2001-10-09 Hitachi Chemical Research Center, Inc. Method for measuring messenger RNA
EP0688358A4 (en) 1993-03-12 1997-10-01 Univ Creighton IMPROVED VECTORS FOR GENTHERAPY
US5808043A (en) * 1995-01-18 1998-09-15 Pharmacia Biotech Inc. Composition for stabilization of labelled nucleoside triphosphates and methods for using same
US20030190753A1 (en) * 1995-11-09 2003-10-09 Nature Technology Corporation Vectors for gene transfer
CN1331700A (zh) 1998-11-16 2002-01-16 基因纬生物技术公司 通过禽类中使用多核苷酸疫苗接种生成抗体的方法
US20070082354A1 (en) * 2005-09-26 2007-04-12 Nexttec Gmbh Method for Isolating RNA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
EP0105141A3 (en) * 1982-09-09 1985-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant dna molecules, process for their production, their use for production of hepatitis b surface antigen (hbsag) and pharmaceutical compositions containing this hbsag
FR2559159B1 (fr) * 1984-02-02 1986-09-12 Inst Nat Sante Rech Med Vecteurs viraux de clonage et d'expression d'une proteine dans une cellule eucaryote, comportant au moins une partie du genome d'un retro-virus; cellules eucaryotes transfectees; procede utilisant de telles cellules et proteines obtenues
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo

Also Published As

Publication number Publication date
DK279686A (da) 1986-06-13
ZA857862B (en) 1986-05-28
ES548529A0 (es) 1988-04-16
JPS62501398A (ja) 1987-06-11
ES8800985A1 (es) 1987-12-16
WO1986002380A1 (fr) 1986-04-24
PT81306B (fr) 1987-03-25
FI862517A0 (fi) 1986-06-12
NO862383L (no) 1986-06-16
DE3574732D1 (de) 1990-01-18
PT81306A (fr) 1985-11-01
ES557463A0 (es) 1987-12-16
FI862517A (fi) 1986-06-12
EP0178996A1 (fr) 1986-04-23
GR852500B (es) 1986-02-18
ATE48642T1 (de) 1989-12-15
AU5010585A (en) 1986-05-02
EP0178996B1 (fr) 1989-12-13
US4957865A (en) 1990-09-18
FR2571737B1 (fr) 1987-02-20
FR2571737A1 (fr) 1986-04-18
BR8506990A (pt) 1987-01-06
NO862383D0 (no) 1986-06-16
DK279686D0 (da) 1986-06-13

Similar Documents

Publication Publication Date Title
ES8900170A1 (es) Procedimiento de modificacion de celulas eucariotas.
JPS5714599A (en) Improved vector,manufacture of vector of this kind and expression of cloning gene
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
EP0112149A3 (en) Molecular cloning and characterization of a further gene sequence coding for human relaxin
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK0408461T3 (da) Protein med uratoxidase-aktivitet, rekombinant gen, der koder for proteinet, samt ekspressionsvektor, mikroorganismer og transformerede celler
DE3486040T2 (de) Klonierung und verwendung von aminotransferase-genen.
EP0177153A3 (en) Interferon-cyclaradine combination
ATE173762T1 (de) Klonierung der n-methylhydantoinase
ES2080486T3 (es) Sg(beta)-1,4-galactanasa y una secuencia de adn.
DE3586830T2 (de) Verfahren zur ligation von heterogenen genen.
FI840104A (fi) Rekombinant-dna-expressionsvektorer anvaendbara i bacillus- och andra vaerdceller.
DK493788A (da) Rekombinant-dna-udtrykkelsesvektorer og dna-forbi ndelser, der indkoder isopenicillin n synthetase fra aspergillus nidulans
IE810767L (en) Prepartion of 2, 2, 6, 6-tetramethylpiperidone-4.
AU7514087A (en) Vaccine containing the protein f of the aids virus
DE3679379D1 (de) Streptomycinsensitives gen mit einer vielzahl von klonierungsstellen, dieses gen enthaltender plasmidvektor und diesen vektor enthaltender mikroorganismus.
NO874490D0 (no) Kloning og anvendelse av transaminasegenet ilv-e.
ZA898479B (en) Injury-stimulated dna sequence from solanum tuberosum,and use thereof
DK631387D0 (da) Virusvektor
NO885645L (no) Beskyttende belegg for baererstavene til forbrente anoder og den utstikkende del hos anodene.
AR245956A1 (es) Vector de adn, cepa bacteriana que lo contiene y metodo para modificar geneticamente una celula vegetal
ZA851996B (en) Purification,cloning and characterization of the gene for interleukin 1
ES8802075A1 (es) Procedimiento para la multiplicacion de un adn heterologo
IT8721615A0 (it) Clonaggio del gene dell'isoamilasi.